| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Common Stock | Options Exercise | $679K | +10K | +50.21% | $67.85 | 29.9K | May 28, 2021 | Direct | F1 |
| transaction | IDXX | Common Stock | Sale | -$581K | -1.04K | -3.47% | $558.89 | 28.9K | May 28, 2021 | Direct | F2 |
| transaction | IDXX | Common Stock | Sale | -$767K | -1.37K | -4.74% | $559.77 | 27.5K | May 28, 2021 | Direct | F3 |
| transaction | IDXX | Common Stock | Sale | -$714K | -1.27K | -4.63% | $560.79 | 26.2K | May 28, 2021 | Direct | F4 |
| transaction | IDXX | Common Stock | Sale | -$803K | -1.43K | -5.45% | $561.77 | 24.8K | May 28, 2021 | Direct | F5 |
| transaction | IDXX | Common Stock | Sale | -$1.39M | -2.46K | -9.93% | $562.65 | 22.3K | May 28, 2021 | Direct | F6 |
| transaction | IDXX | Common Stock | Sale | -$966K | -1.71K | -7.67% | $564.04 | 20.6K | May 28, 2021 | Direct | F7 |
| transaction | IDXX | Common Stock | Sale | -$290K | -513 | -2.49% | $564.73 | 20.1K | May 28, 2021 | Direct | F8 |
| transaction | IDXX | Common Stock | Sale | -$113K | -200 | -0.99% | $565.56 | 19.9K | May 28, 2021 | Direct | F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -10K | -79.2% | 2.63K | May 28, 2021 | Common Stock | 10K | $67.85 | Direct | F10, F11 |
| Id | Content |
|---|---|
| F1 | Includes 12 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021. |
| F2 | Represents the weighted average price of the shares sold ranging from a low of $558.22 to a high of $559.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F3 | Represents the weighted average price of the shares sold ranging from a low of $559.23 to a high of $560.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F4 | Represents the weighted average price of the shares sold ranging from a low of $560.24 to a high of $561.24 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F5 | Represents the weighted average price of the shares sold ranging from a low of $561.25 to a high of $562.24 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F6 | Represents the weighted average price of the shares sold ranging from a low of $562.26 to a high of $563.155 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F7 | Represents the weighted average price of the shares sold ranging from a low of $563.36 to a high of $564.33 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F8 | Represents the weighted average price of the shares sold ranging from a low of $564.38 to a high of $564.88 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F9 | Represents the weighted average price of the shares sold ranging from a low of $565.42 to a high of $565.69 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| F10 | Grant of option to buy 12,627 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2017. |
| F11 | Not applicable. |